Dolinna, M.O. and Svyntozelskyi, O.O. 2020. Influence of angiotensin-converting enzyme inhibitor ramipril on indicators of tubular kidney lesion in patients with chronic glomerulonephritis. Current Issues in Pharmacy and Medical Sciences. 33, 1 (Mar. 2020), 17–20. DOI:https://doi.org/10.2478/cipms-2020-0005.